Obesity & Metabolic Health - Panel: How is innovation in weight loss drugs changing @WithTheEconomist
Obesity & Metabolic Health - Panel: How is innovation in weight loss drugs changing @WithTheEconomist
Uploaded June 2026 | Updated September 2026, 24 minutes ago
What should be done to maximise the gains from obesity treatment. Scaleability, accessibility and ease of delivery will be critical. Are health systems prepared logistically to meet the demand when generic versions arrive? How could oral formulations reduce these challenges and benefit patients? How should patient management and support change to ensure oral drugs achieve optimum results?
Obesity & Metabolic Health - Panel: How is innovation in weight loss drugs changingPanel. Decoding longevity: live long and prosperSponsored reel. Panel. Can Asia deliver on green growth through regional collaboration?Panel. Why hydrogen — is Europe sitting on a goldmine that might transform transport?From pilots to platforms: what will change for organisations once they reach quantum advantage?Fireside chat. Demo is not destiny: from first light to fast followersKeynote panel. The thinking grid: can AI keep the lights on?Panel. Responsible in orbit, sustainable on Earth: can space power Europe’s climate transition?Panel The secret sauce of sensingPanel. The superposition of utility and hype: removing the obstacles to a quantum-powered futureKeynote panel. The business case for CCUS: how and why it fits into decarbonisation strategyPanel. Decarbonising Data — AIs energy footprint
Economist Enterprise – Events |

Obesity & Metabolic Health - Panel: How is innovation in weight loss drugs changing

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER